Home / News / India News / Article / Bharat Biotech dossier under review for Covaxin emergency use listing: WHO

Bharat Biotech dossier under review for Covaxin emergency use listing: WHO

Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said India has been offered 7.5 million doses of Moderna vaccine through WHO's Covid-19 Vaccines Global Access (COVAX) program

Listen to this article :
Photo used for representational purpose. Pic/AFP

Photo used for representational purpose. Pic/AFP

Officials of the World Health Organisation (WHO) had a meeting with the Hyderabad-based vaccine maker Bharat Biotech and its dossier for Emergency Use Listing (EUL) of Covaxin is under review by technical experts for consideration, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said on Monday.

Dr Singh said that India has been offered 7.5 million doses of Moderna vaccine through WHO's Covid-19 Vaccines Global Access (COVAX) program.

How do you like the new new mid-day.com experience? Share your feedback and help us improve.

Read Next Story
Congress plans nationwide agitation on 'Pegasus Project' report

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement